Inmunotherapy

  • To investigate new immunotherapeutic approaches: check-point inhibitors, Chimeric Antigenic Receptor T-cells (CAR-T), B-cell Antigenic Receptor T-cells (BAR-T), etc
  • To develop new therapeutic interventions
  • To evaluate new inmunotherapies
  • To create a Cellular Therapy Banking